A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)

NCT00561574 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

259

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorder; Elderly
Mental Disorder
Dyssomnias
Sleep Disorders
Sleep Disorder, Intrinsic

Interventions

DRUG: Esmirtazapine

Sponsor

Merck Sharp & Dohme LLC